UNSPSC 85703054: Supplement right fibula with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right fibula with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QUJ0KZ

UNSPSC 85703054 Supplement right fibula with nonautologous tissue substitute, open approach is a Commodity code that does not reflect the scope of recent state and local contract activity posted under this code designation. The recent opportunities show no procurement of surgical implants, orthopedic devices, or surgical procedures; instead, they span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluations for pension disability determinations, surgical center-of-excellence network carve-outs, and emergency medical services for detained youth. The code as named describes a specific surgical procedure with a tissue substitute implant, but the contracting activity tagged under it encompasses administrative healthcare services, medical staffing, benefit plan management, and occupational health compliance—none of which align with prosthetic or implant procurement or surgical execution.

Activity under this code appears limited and misaligned with its stated scope. Recent opportunities originate from diverse issuing bodies including county health systems (Santa Clara), county commissioners offices (Collier County, Harris County), state transportation departments (Washington Department of Transportation), municipal retirement boards (City of Phoenix), and municipal employee benefit programs (City of Long Beach), but none solicit orthopedic implants, surgical procedures, or fibular supplementation services. The geographic spread covers Arizona, California, Florida, Texas, and Washington, with response dates clustering between September and October 2026. Without evidence that state and local buyers are actually procuring fibular implants or related surgical materials under this code, the code shows little decision-relevant procurement activity for suppliers of orthopedic devices or implantable materials.